Skip to content

A Randomized Controlled Study of Shock Wave and Low Frequency Pulsed Laser in the Treatment of Myogenic Temporomandibular Joint Disorders

A Randomized Controlled Study of Shock Wave and Low Frequency Pulsed Laser in the Treatment of Myogenic Temporomandibular Joint Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115083
Enrollment
Unknown
Registered
2025-12-22
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Joint Disorders

Interventions

Extracorporeal Shock Wave Therapy Group(ESWT):Patients receive extracorporeal shock wave therapy on the basis of standardized health education, with a treatment frequency of once a week for 4 consecut
Low-Level Laser Therapy Group(LLLT):Patients receive low-intensity laser therapy (LLLT) on the basis of standardized health education. A total of 4 tender points in the bilateral masseter and temporal

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years old (including 18 and 65), regardless of gender; 2. Meeting the diagnosis of myofascial pain (with or without referred pain) in the DC/TMD Axis I diagnostic criteria, and having a Visual Analog Scale (VAS, 0-10) score of >= 3 for maxillofacial pain ; 3. Able to understand the research process, with good compliance, and capable of cooperating to complete all assessment and intervention protocols; 4. Being informed of the study details, consenting to participate, and voluntarily signing a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.Active infection in the temporomandibular joint area or head and face, damaged skin at the treatment site, or oral mucosal ulcers in the electrode placement area, which are unsuitable for assessment or treatment; 2.Patients with inflammatory joint diseases (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, etc.) or complicated with uncontrolled severe systemic diseases (such as diabetes, malignant tumors, cardiovascular and cerebrovascular diseases, hepatic and renal failure, etc.); 3.Patients with contraindications to shock wave therapy (such as coagulation disorders, being on anticoagulant drugs, malignant tumors in the treatment area, etc.); 4.Unstable occlusal relationship due to dentition defect (excluding third molars), severe tooth wear, or orthodontic treatment, or inability to complete basic oral functional movements such as maximum intercuspal position occlusion; 5.Women who are known to be pregnant or lactating; 6.Patients with severe mental or cognitive disorders who cannot understand and cooperate with research questionnaires, clinical assessments, and treatment operations; 7.Use of rapid-acting analgesics or muscle relaxants within 24 hours before enrollment, which may interfere with baseline assessment results.

Design outcomes

Primary

MeasureTime frame
Pain Intensity (Visual Analog Scale, VAS);

Secondary

MeasureTime frame
Mandibular Range of Motion;Pressure Pain Threshold (PPT);Surface Electromyography (sEMG);Degree of Mandibular Function Limitation;TMD-related kinesiophobia;Head and Neck Posture Assessment;Oral Behavioral Habits;Depressive Symptoms;Anxiety Symptoms;Somatization Symptoms;Pain Catastrophizing;Sleep Quality;

Countries

China

Contacts

Public ContactLili Xu

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

heblll@163.com+86 182 2187 8206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026